QSAR Models Using a Large Diverse Set of Estrogens

Journal of Chemical Information and Computer Sciences

Volumn 41, Issue 1, 2001, Pages 186-195

  Shi, Leming M ^a,c   Fang, Hong ^a   Tong, Weida ^a   Wu, Jie ^a   Perkins, Roger ^a   Blair, Robert M ^b   Branham, William S ^b   Dial, Stacy L ^b   Moland, Carrie L ^b   Sheehan, Daniel M ^b  

^a Logicon ROW Sciences   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^c BASF CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR;

ANIMAL; ARTICLE; BINDING COMPETITION; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; METABOLISM; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RAT;

ANIMALS; BINDING, COMPETITIVE; ESTROGENS; MODELS, MOLECULAR; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RATS; RECEPTORS, ESTROGEN;

EID: 18044382708     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci000066d     Document Type: Article

References (39)

1. Kavlock, R. J.; Daston, G. P.; DeRosa, C.; Fenner-Crisp, P.; Gray, L. E.; Kaattari, S.; Lucier, G.; Luster, M.; Mac, M. J.; Maczka, C.; Miller, R.; Moore, J.; Rolland, R.; Scott, G.; Sheehan, D. M.; Sinks, T.; Tilson, H. A. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. Environ. Health Perspect. 1996, 104, Suppl 4, 715-740.
2. Cooper, R. L.; Kavlock, R. J. Endocrine disruptors and reproductive development: a weight-of-evidence overview. J. Endocrinol. 1997, 152, 159-166.
3. Colborn, T. Environmental estrogens: health implications for humans and wildlife. Environ. Health Perspect. 1995, 103, Suppl 7, 135-136.
4. Colborn, T.; vom Saal, F. S.; Solo, A. M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans [see comments]. Environ. Health Perspect. 1993, 101, 378-384.
5. U.S. Congress. The Food Quality Protection Act (FQPA) and the Safe Drinking Water Act (SDWA), 1996.
6. EDSTAC. http://www.epa.gov/opptintr/opptendo/finalrpt.htm.
7. Shi, L. M.; Tong, W.; Fang, H.; Perkins, R.; Wu, J.; Tu, M.; Blair, R.; Branham, W.; Waller, C.; Sheehan, D. An integrated "Four-Phase" approach for priority setting of endocrine disruptors - Part 1: Phase I and II for prediction of potential estrogenic endocrine disruptor. SAR QSAK Environ. Res. 2000. submitted for publication.
8. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev. 1997, 23, 3-25.
9. Walker, J. D.; Waller, C. W.; Kane, S. The Endocrine Disruption Priority Setting Database (EDPSD): A Tool to Rapidly Sort and Prioritize Chemicals for Endocrine Disruption Screening and Testing; Walker, J. D., Ed.; SETAC: 2000.
10. Hansch, C.; Leo, A. Exploring QSAR - Fundamentals and applications in chemistry and biology. American Chemical Society: Washington, DC, 1995.
11. Tong, W.; Perkins, R.; Strelitz, R.; Collantes, E. R.; Keenan, S.; Welsh, W. J.; Branham, W. S.; Sheehan, D. M. Quantitative structure - activity relationships (QSARs) for estrogen binding to the estrogen receptor: predictions across species. Environ. Health Perspect. 1997, 105, 1116-1124.
12. Tong, W.; Perkins, R.; Xing, L.; Welsh, W. J.; Sheehan, D. M. QSAR models for binding of estrogenic compounds to estrogen receptor alpha and beta subtypes. Endocrinology 1997, 138, 4022-4025.
13. Tong, W.; ,Lowis, D. R.; Perkins, R.; Chen, Y.; Welsh, W. J.; Goddette, D. W.; Heritage, T. W.; Sheehan, D. M. Evaluation of quantitative structure - activity relationship methods for large-scale prediction of chemicals binding to the estrogen receptor. J. Chem. Inf. Comput. Sci. 1998, 38, 669-677.
14. Bradbury, S.; Mekenyan, O.; GT, A. Quantitative structure - activity relationships for polychlorinated hydroxybiphenyl estrogen receptor binding affinity- An assessment of conformer flexibility. Environ. Toxicol. Chem. 1996, 15, 1945-1954.
15. Waller, C. L.; Oprea, T. I.; Chae, K.; Park, H. K.; Korach, K. S.; Laws, S. C.; Wiese, T. E.; Kelce, W. R.; Gray, L. E., Jr. Ligandbased identification of environmental estrogens. Chem. Res. Toxicol. 1996, 9, 1240-1248.
16. Wiese, T. E.; Polin, L. A.; Palomino, E.; Brooks, S. C. Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogues of estradiol-17 β: a 3D QSAR study. J. Med. Chem. 1997. 40, 0, 3659-3669.
17. Xing, L.; Welsh, W. J.; Tong, W.; Perkins, R.; Sheehan, D. M. Comparison of estrogen receptor alpha and beta subtypes based on comparative molecular field analysis (CoMFA). SAR QSAR Environ. Res. 1999, 10, 215-237.
18. 2-guided region selection approach. J. Med. Chem. 1998, 41, 2261-2267.
19. Zheng, W.; Tropsha, A. A novel variable selection QSAR approach based on the k-nearest neighbor principle. J. Chem. Inf. Comput. Sci. 2000, 40, 185-194.
20. Blair, R.; Fang, H.; Branham, W. S.; Hass, B.; Dial, S. L.; Moland, C. L.; Tong, W.; Shi, L.; Perkins, R.; Sheehan, D. M. Estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. Toxicol. Sci. 2000, 54, 138-153.
21. Branham, W. S.; Dial, S. L.; Moland, C. L.; Hass, B.; Blair, R.; Fang, H.; Shi, L.; Tong, W.; Perkins, R.; Sheehan, D. M. Phytoestrogen and mycoestrogen binding to rat uterine estrogen receptor. Am. J. Nutr. 2000, in press.
22. Perkins, R.; Anson, J.; Branham, W.; Fang, H.; Tong, W.; Welsh, W.; Chen, Y.; Meehan, J.; Jackson, M.; Nossaman, R.; Shi, L.; Sheehan, D. The Estrogen Knowledge Base (EKB). A Prototype Toxicological Knowledge Base for Endocrine Disrupting Compounds; Walker, J. D., Ed.; SETAC: 2000.
23. Fang, H.; Tong, W.; Perkins, R.; Soto, A.; Prechtl, N.; Sheehan, D. M. Quantitative comparison of in vitro assays for estrogenic activity. Environ. Health Perspect. 2000, 108, 723-729.
24. Zacharewski, T. Identification and assessment of endocrine disruptors: limitations of in vivo and in vitro assays. Environ. Health Perspect. 1998, 106, Suppl 2, 577-582.
25. Kuiper, G. G.; Lemmen, J. G.; Carlsson, B.; Corton, J. C.; Safe, S. H.; van der Saag, P. T.; van der Burg, B.: Gustafsson, J. A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139, 4252-4263.
26. Brzozowski, A. M.; Pike, A. C.; Dauter, Z.; Hubbard, R. E.; Bonn, T.; Engstrom, O.; Ohman, L.; Greene, G. L.; Gustafsson, J. A.; Carlquist, M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997, 389, 753-758.
27. Shiau, A. K.; Barstad, D.; Loria, P. M.; Cheng, L.; Kushner, P. J.; Agard, D. A.; Greene, G. L. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 1998, 95, 927-937.
28. von Angerer, E. The estrogen receptor as a target for rational drug design; R.G. Landes Co.: Georgetown, TX, 1995.
29. Anstead, G. M.; Carlson, K. E.; Katzenellenbogen, J. A. The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Steroids 1997, 62, 268-303.
30. Bucourt, R.; Vignau, M.; Torelli, V. New Biospecific adsorbents for the purification of estradiol receptor. J. Biol. Chem. 1978, 253, 8221-8228.
31. Fang, H.; Tong, W.; Shi, L.; Blair, R.; Perkins, R.; Branham, W. S.; Dial, S. L.; Moland, C. L.; Sheehan, D. M Structure activity relationship for a large diverse set of natural, synthetic and environmental chemicals. Chem. Res. Toxicol. 2000, in press.
32. Cramer, R. D. I.; Bunce, J. D.; Patterson, D. E. Crossvalidation, bootstrapping, and partial least squares compared with multiple regression in conventional QSAR studies. QSAR 1988, 7, 18-25.
33. Cramer, R. D.; Patterson, D. E.; Bunce, J. D. Comparative molecular field analysis (CoMFA). I. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
34. 2-guided region selection for comparative molecular field analysis: a simple method to achieve consistent results. J. Med. Chem. 1995, 38, 1060-1066.
35. Wang, R.; Gao, Y.; Lin, L.; Lai, L. All orientation search and all-placement search in Comparative Molecular Field Analysis. J. Mol. Model. 1998, 4, 276-283.
36. Tong, W.; Collantes, E. R.; Chen, Y.; Welsh, W. J. A comparative molecular field analysis study of N-benzylpiperidines as acetylcholinesterase inhibitors. J. Med. Chem. 1996, 39, 380-387.
37. Tong, W.; Collantes, E. R.; Welsh, W. J.; Berglund, B. A.; Howlett, A. C. Derivation of a pharmacophore model for anandamide using constrained conformational searching and comparative molecular field analysis. J. Med. Chem. 1998, 41, 4207-4215.
38. Welsh, W. J.; Tong, W. D.; Collantes, E. R.; Chickos, J. S.; Gagarin, S. G. Enthalpies of sublimation and formation of polycyclic aromatic hydrocarbons (PAHs) derived from comparative molecular field analysis (CoMFA)-Application of moment of inertia for molecular alignment. Thermochim. Acta 1997, 290, 55-64.
39. Welsh, W.; Tong, W.; Collantes, E. Heats of sublimition and formation of polycyclic aromatic hydrocarbons (PAHs) derived from comparative molecular field analysis (CoMFA): Application of moment of inertia for molecular alignment. Thermochim. Acta 1996, 290, 55-64.